AI-generated summary
The authors developed gold nanorods coated with a photosensitizer (HB) and a tumor-targeting peptide (cRGD) for single near-infrared laser-triggered photodynamic and photothermal therapy. In experiments on ECA109 esophageal cancer models, they report a tumor inhibition rate of about 77.04% and negligible systemic toxicity. The abstract describes this as a promising strategy, but the study design and sample details are not stated.
- Who or what was studied
- ECA109 esophageal cancer model (animal model; details not stated in the abstract)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports preclinical findings only and does not state sample size, control groups, or the size of any effect beyond the single tumor inhibition figure.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Near-infrared, Laser, Reactive oxygen species, Photodynamic therapy, Phototherapy, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.